Additional file 1: of Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach

Table S1. Sample information for the FISS transcriptome profiling. Each row corresponds to an RNA sample. Columns are as follows: sample name, the coded sample name used within this manuscript; biosample type, indicates whether the sample came from primary tissue or cultured cells; normal or cancer, distinguishes whether the sample is normal or cancerous; tissue type, gives the tissue subtype, such as sarcoma, skin, or muscle; Cat, the coded cat patient ID for this study; batch, the mRNA-seq batch number (see Methods); “#reads”, the total number of reads derived from the sample; “#uniquely mapped reads”, the number of reads that mapped to a unique location in the cat genome; %alignment, the percentage of the total number of reads that aligned to a unique location in the cat genome; #genes with non-zero count, the number of genes for which the count of aligned reads is greater than zero. (XLSX 11 kb)

表S1 FISS转录组测序分析的样本信息。每一行对应一个RNA样本，各列说明如下：样本名称：本文稿中使用的编码化样本名；生物样本类型：表明样本源自原代组织还是培养细胞；正常/癌性状态：区分样本为正常样本还是癌性样本；组织类型：说明组织亚型，例如肉瘤、皮肤或肌肉组织；猫个体编号：本研究中使用的编码化猫个体患者ID；测序批次：mRNA测序的批次编号（详见方法部分）；总测序读段数（"#reads"）：该样本产出的全部读段总数；唯一比对读段数（"#uniquely mapped reads"）：比对至猫基因组唯一位置的读段数量；比对率（"%alignment"）：比对至猫基因组唯一位置的读段占总读段数的百分比；非零计数基因数（"#genes with non-zero count"）：比对读段计数大于零的基因数量。（XLSX格式，文件大小11 KB）